Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085437 (
bacterial meningitis
)
4,038
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Escherichia coli is the leading cause of neonatal Gram-negative
bacterial meningitis
, but the pathogenesis of E. coli meningitis remains elusive. E. coli penetration of the blood-brain barrier (BBB) is the critical step for development of meningitis. Here, we identify
Caspr1
, a single-pass transmembrane protein, as a host receptor for E. coli virulence factor IbeA to facilitate BBB penetration. Genetic ablation of endothelial
Caspr1
and blocking IbeA-
Caspr1
interaction effectively prevent E. coli penetration into the brain during meningitis in rodents. IbeA interacts with extracellular domain of
Caspr1
to activate focal adhesion kinase signaling causing E. coli internalization into the brain endothelial cells of BBB. E. coli can invade hippocampal neurons causing apoptosis dependent on IbeA-
Caspr1
interaction. Our results indicate that E. coli exploits
Caspr1
as a host receptor for penetration of BBB resulting in meningitis, and that
Caspr1
might be a useful target for prevention or therapy of E. coli meningitis.
...
PMID:Caspr1 is a host receptor for meningitis-causing Escherichia coli. 3028 Jan 4